Liver fibrosis, not steatosis, associates with long-term outcomes in ischaemic stroke patients
Cerebrovascular Diseases Feb 19, 2019
Baik M, et al. - In patients with ischemic stroke or transient ischemic attack (TIA), researchers studied if long-term all-cause and cardiovascular mortality vary depending on the burden of liver fibrosis or steatosis. Consecutive patients with acute ischemic stroke or TIA were considered eligible for transient elastography (TE) from January 2014 to December 2014. Using Cox proportional hazard models, the influence of liver fibrosis or steatosis evaluated via TE on long-term outcomes was investigated. In patients with ischemic stroke, the burden of liver fibrosis, but not steatosis, as evaluated by TE, independently predicts all-cause and cardiovascular mortality during long-term follow-up.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries